Lewes, DE -- (SBWire) -- 11/21/2016 --This Competitive Intelligence report about Activators of Immune Checkpoints CD40, GITR, OX40, 4-1BB, CD27 & ICOS provides a competitor evaluation as of November 2016 in the field of antibodies, proteins and vaccines stimulating immune checkpoints from the TNF receptor and the B7-CD28 superfamilies, including
- CD40 (TNFSFR5)
- GITR (Glucocorticoid-Induced Tumor Necrosis Factor Receptor; TNFSFR18)
- OX40 (CD134; TNFSFR4)
- 4-1BB (CD137; TNFSFR9)
- CD27 (TNFSFR7)
- ICOS (Inducible Co-Stimulator)
More than 20 immune checkpoint agonistic antibodies are in clinical development as monotherapy or in combination with other checkpoint modulators or targeted cancer therapeutics. At least further six molecules are undergoing IND-enabling studies.
The report includes a compilation of currently active projects in research and development of immune checkpoint activators. In addition, the report lists company-specific R&D pipelines of PD-1 and PD-L1 Immune Checkpoint Inhibitors.
Competitor projects are listed in a tabular format providing information on:
- Drug Codes,
- Target / Mechanism of Action,
- Class of Compound,
- Company,
- Product Category,
- Indication,
- R&D Stage and
About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
For more information Visit at: http://www.marketresearchreports.com/la-merie-publishing/competitor-analysis-activators-immune-checkpoints-cd40-gitr-ox40-4-1bb-cd27-icos
Find all Biotechnology Reports at: http://www.marketresearchreports.com/biotechnology
About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.
Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions
Global Activators of Immune Checkpoints CD40, GITR, OX40, 4-1BB, CD27 & ICOS; New Report Launched
Market Research Reports, Inc. has announced the addition of “Competitor Analysis: Activators of Immune Checkpoints CD40, GITR, OX40, 4-1BB, CD27 & ICOS” research report to their website www.MarketResearchReports.com